Bauminas Acquires Kemira’s Brazilian Iron and Aluminium Coagulant Business

Kemira and Bauminas have signed a contract today according to which Kemira sells its Brazilian iron and aluminium coagulant business to Bauminas. The deal includes coagulant business related assets, liabilities and personnel of Kemira WaterSolutions Brazil Ltda and shares of Nheel Quimica Ltda as well as its three coagulants manufacturing sites in Brazil (Rio Claro, Araporti and Lages).

The sold businesses have combined reported revenue of approximately EUR 50 million, mainly in Kemira's Municipal & Industrial segment. 193 employees will be transferred to Bauminas as part of the transaction. The transaction is subject to fulfillment of certain conditions and the closing is still expected during the fourth quarter of 2013.

The parties have agreed not to disclose the transaction price. The transaction proceeds are expected to have a positive impact on Kemira's cash flow at closing. Kemira will undertake a non-recurring write-down related to the transaction of approximately EUR 40 million, impacting Kemira's reported EBIT in the fourth quarter of 2013.

"The divestment of our coagulant business in Brazil is well in line with our focus on profitability improvement and cash flow maximization in the Municipal & Industrial segment. Kemira's strategy continues to be focused on those businesses and geographies, where we can achieve a sustainable competitive market position in combination with growth. Exiting the coagulants business in Brazil will further improve the EBIT margin in the Municipal & Industrial segment and will have a positive cash flow impact as well. Brazil will remain an important market for Kemira, especially for the chemicals used in the pulp and paper industry" said Wolfgang Büchele, Kemira's President and CEO.

For more information, please contact

Kemira Oyj
Frank Wegener, President, Municipal & Industrial segment
+49 171 588 8107

Jukka Ryhänen, Director, Mergers & Acquisitions
+358 50 525 2354

Tero Huovinen, VP, Investor Relations
+358 10 862 1980

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.